NCT07047729 COMPARATIVE OUTCOME OF EARLY AND STANDARD ORAL FEEDING AFTER EMERGENCY BOWEL SURGERY
| NCT ID | NCT07047729 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr Hamail Khanum |
| Condition | Bowel Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-03-06 |
| Primary Completion | 2025-09-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-03-06 with a primary completion date of 2025-09-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Informed consent will be obtained from patients or their legal representatives in cases where the patient is unconscious. Patient information, including names, ages, gender, smoking history, comorbidities, and the indication for emergency surgical procedures, will be documented. All surgical procedures will follow standard protocols and will be conducted by a single surgical team led by at least two consultants, each with more than five years of experience. All 60 patients will be randomly allocated into two groups using a random number table: Group A (early oral feeding), consisting of 30 patients, and Group B (standard oral feeding), consisting of 30 patients. In Group A, a liquid diet will be initiated within 24 hours after surgery and, if well-tolerated without vomiting, will transition to a regular diet over the subsequent 24 hours. On the other hand, in Group B, a standard diet (late feeding), including liquid filtrates, will only be introduced after the resolution of the ileus, during which these patients will remain NPO (nothing by mouth).
Eligibility Criteria
Inclusion Criteria: * Either Gender * Requiring emergency surgery due to conditions such as obstructive bowel disease, GI perforation, colorectal surgery, blunt abdominal trauma (resulting from falls or roadside accidents), and penetrating abdominal trauma (involving firearm injuries and stab wounds). Exclusion Criteria: * Patients with terminal cancer need palliative surgery (as their focus is on comfort care rather than surgical intervention). * Patients who had undergone surgery within the past 30 days (to avoid potential complications associated with recent surgical procedures). * Patients receive regular renal replacement therapy (to prevent additional stress on their medical condition). * Pregnant women (as surgical interventions may pose risks to both the mother and the unborn child).
Contact & Investigator
Professor Dr Maratab Ali, MBBS FCPS
STUDY DIRECTOR
Gulab Devi Hospital
Frequently Asked Questions
Who can join the NCT07047729 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bowel Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07047729 currently recruiting?
Yes, NCT07047729 is actively recruiting participants. Contact the research team at umnahnoor@gmail.com for enrollment information.
Where is the NCT07047729 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07047729 clinical trial?
NCT07047729 is sponsored by Dr Hamail Khanum. The principal investigator is Professor Dr Maratab Ali, MBBS FCPS at Gulab Devi Hospital. The trial plans to enroll 60 participants.